Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    TopAbstracts in Hypertension 07/01/2009 - (DGNews)
    Certain Biomarkers Have Limitations in Predicting Cardiovascular Events - (DGNews)
    Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study - (BMJ)
    TopAbstracts in Hypertension 06/24/2009 - (DGNews)
    TopAbstracts in Hypertension 06/17/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Hypertension
    Thrombotic Thrombocytopenic Purpura: The Masquerader
    Innovative Strategies in Cardiometabolic Risk Reduction
    Diuretics for the Treatment of Hypertension
    Managing Hypertension: Addressing the Challenges in Special Populations

    Webcasts/CME archive

     Recent cases - Hypertension
      Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
      Malignant Hypertension and Acute Aortic Dissection Associated with Caffeine-Based Ephedra-Free Dietary Supplements: A Case Report
      Giant Right Coronary Artery Aneurysm: Case Report and Literature Review
      Normalization of Systemic Arterial Hypertension Following Removal of Posterior Fossa Hemangioblastoma: A Case Report
      Headache and Seizure on Postpartum Day 5: Late Postpartum Eclampsia

      Cases archive
        




      my personal edition > hypertension > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Orlistat Lowers Blood Pressure In Obese People With Inadequately Controlled Hypertension

      A DGReview of :"Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension."
      Journal of Hypertension

      11/12/2002
      By Mark Greener


      Orlistat lowers blood pressure and reduces cardiovascular risk in obese people with inadequately controlled hypertension more effectively than does diet alone.

      This is the result of a year-long prospective, randomized, double-blind, placebo multicenter trial undertaken by researchers from Rush University Hypertension/Clinical Research Center, Chicago, and other American centres including Roche Laboratories, New Jersey, United States.

      All patients were given a 600 kcal deficient diet that provided 30 percent or less of the calories from fat. The patients were also randomized to receive orlistat or placebo.

      The patients taking orlistat showed greater weight loss than those on diet alone: reductions of 5.4 and 2.7 kg respectively. Body mass also declined by a greater amount among those in the orlistat group compared to diet alone: reductions of 1.9 and 0.9 kg /m2 respectively. Furthermore, 46 percent of those taking orlistat and 23 percent of those in the placebo arm lost at least 5 percent of their body weight.

      Diastolic blood pressure declined to a greater extent among those taking orlistat than in the placebo group: 11.4 and 9.2 mmHg respectively. Moreover, 67 percent of the orlistat arm reached their target diastolic blood pressure (90 mmHg or a decline of at least 10 mmHg) compared to 53 percent of the diet alone group.

      Those treated with orlistat also showed greater reductions in levels of total cholesterol, low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol. Overall, 36.1 percent of the orlistat users showed a reduction of at least 30 percent in their cardiovascular risk compared to 24.0 percent of the diet alone group.

      The authors concluded that a weight-loss programme that incorporates orlistat lowers blood pressure and reduces cardiovascular risk more effectively than diet alone.
      J Hypertens 2002; 20:2257-2267. "Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension."

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send